DRUG POLICY ALLIANCE

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $82,977 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. Everything on this page is grouped by the registrant's LDA id (68651), not by name.

Clients 1

DRUG POLICY ALLIANCE $82,977 6 filings

Lobbyists named 1

HANNA SHARIF-KAZEMI 6 filings · through 2026 Policy Manager

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $18,639 2 filings
2025 $64,338 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Recent filings 6 total

Q2

DRUG POLICY ALLIANCE

2nd Quarter (Apr 1 - June 30) 2026 · $18,639 expenses · posted Jul 17, 2026

View → Q1

DRUG POLICY ALLIANCE

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 19, 2026

View → Q4

DRUG POLICY ALLIANCE

4th Quarter (Oct 1 - Dec 31) 2025 · $7,971 expenses · posted Jan 18, 2026

View → Q3

DRUG POLICY ALLIANCE

3rd Quarter (July 1 - Sep 30) 2025 · $25,000 expenses · posted Oct 18, 2025

View → Q2

DRUG POLICY ALLIANCE

2nd Quarter (Apr 1 - June 30) 2025 · $21,013 expenses · posted Jul 21, 2025

View → Q1

DRUG POLICY ALLIANCE

1st Quarter (Jan 1 - Mar 31) 2025 · $10,353 expenses · posted Apr 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.